VPS35 (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "VPS35" in English language version.

refsWebsite

Global rank English rank

34nih.gov

4^th place

22doi.org

2^nd place

8semanticscholar.org

11^th place

8^th place

2ensembl.org

1,626^th place

1,007^th place

1sorbonne-universite.fr

low place

doi.org

Reitz C (April 2015). "The role of the retromer complex in aging-related neurodegeneration: a molecular and genomic review". Molecular Genetics and Genomics. 290 (2): 413–27. doi:10.1007/s00438-014-0939-9. PMC 4363161. PMID 25332075.
Reitz C (May 2018). "Retromer Dysfunction and Neurodegenerative Disease". Current Genomics. 19 (4): 279–288. doi:10.2174/1389202919666171024122809. PMC 5930449. PMID 29755290.
Brodin L, Shupliakov O (2018). "Retromer in Synaptic Function and Pathology". Frontiers in Synaptic Neuroscience. 10: 37. doi:10.3389/fnsyn.2018.00037. PMC 6207580. PMID 30405388.
Follett J, Bugarcic A, Collins BM, Teasdale RD (2017-07-01). "Retromer's Role in Endosomal Trafficking and Impaired Function in Neurodegenerative Diseases". Current Protein & Peptide Science. 18 (7): 687–701. doi:10.2174/1389203717666160311121246. PMID 26965691.
Trousdale C, Kim K (November 2015). "Retromer: Structure, function, and roles in mammalian disease". European Journal of Cell Biology. 94 (11): 513–21. doi:10.1016/j.ejcb.2015.07.002. PMID 26220253.
Rahman AA, Morrison BE (March 2019). "Contributions of VPS35 Mutations to Parkinson's Disease". Neuroscience. 401: 1–10. doi:10.1016/j.neuroscience.2019.01.006. PMC 6422337. PMID 30660673.
Vilariño-Güell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, Lincoln SJ, et al. (July 2011). "VPS35 mutations in Parkinson disease". American Journal of Human Genetics. 89 (1): 162–7. doi:10.1016/j.ajhg.2011.06.001. PMC 3135796. PMID 21763482.
Williams ET, Chen X, Moore DJ (2017-01-01). "VPS35, the Retromer Complex and Parkinson's Disease". Journal of Parkinson's Disease. 7 (2): 219–233. doi:10.3233/JPD-161020. PMC 5438477. PMID 28222538.
Cutillo G, Simon DK, Eleuteri S (November 2020). "VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology". Neurobiology of Disease. 145: 105056. doi:10.1016/j.nbd.2020.105056. PMID 32853677. S2CID 221277514.
Eleuteri S, Albanese A (2019-12-17). "VPS35-Based Approach: A Potential Innovative Treatment in Parkinson's Disease". Frontiers in Neurology. 10: 1272. doi:10.3389/fneur.2019.01272. PMC 6928206. PMID 31920908.
Deng H, Gao K, Jankovic J (May 2013). "The VPS35 gene and Parkinson's disease". Movement Disorders. 28 (5): 569–75. doi:10.1002/mds.25430. PMID 23536430. S2CID 16641707.
Sassone J, Reale C, Dati G, Regoni M, Pellecchia MT, Garavaglia B (April 2020). "The Role of VPS35 in the Pathobiology of Parkinson's Disease". Cellular and Molecular Neurobiology. 41 (2): 199–227. doi:10.1007/s10571-020-00849-8. PMID 32323152. S2CID 216076582.
Vergés M (2016-01-01). Jeon KW (ed.). "Retromer in Polarized Protein Transport". International Review of Cell and Molecular Biology. 323. Academic Press: 129–79. doi:10.1016/bs.ircmb.2015.12.005. ISBN 9780128048085. PMID 26944621.
Ghosh R, Pattison JS (2018). "Macroautophagy and Chaperone-Mediated Autophagy in Heart Failure: The Known and the Unknown". Oxidative Medicine and Cellular Longevity. 2018: 8602041. doi:10.1155/2018/8602041. PMC 5822756. PMID 29576856.
Bose A, Beal MF (October 2016). "Mitochondrial dysfunction in Parkinson's disease". Journal of Neurochemistry. 139 (S1): 216–231. doi:10.1111/jnc.13731. PMID 27546335. S2CID 32612919.
Weissbach A, Wittke C, Kasten M, Klein C (2019-01-01). Stamelou M, Höglinger GU (eds.). "'Atypical' Parkinson's disease - genetic". International Review of Neurobiology. 149. Academic Press: 207–235. doi:10.1016/bs.irn.2019.10.011. ISBN 9780128177303. PMID 31779813. S2CID 208357146.
Kim CY, Alcalay RN (April 2017). "Genetic Forms of Parkinson's Disease". Seminars in Neurology. 37 (2): 135–146. doi:10.1055/s-0037-1601567. PMID 28511254. S2CID 635105.
Lunati A, Lesage S, Brice A (November 2018). "The genetic landscape of Parkinson's disease" (PDF). Revue Neurologique. International SFN/SOMFA Meeting 2018. 174 (9): 628–643. doi:10.1016/j.neurol.2018.08.004. PMID 30245141.
Nguyen M, Wong YC, Ysselstein D, Severino A, Krainc D (February 2019). "Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease". Trends in Neurosciences. 42 (2): 140–149. doi:10.1016/j.tins.2018.11.001. PMC 6452863. PMID 30509690.
Abeysinghe AA, Deshapriya RD, Udawatte C (September 2020). "Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions". Life Sciences. 256: 117996. doi:10.1016/j.lfs.2020.117996. PMID 32585249. S2CID 220075087.
Boche D, Nicoll JA (December 2020). "Invited Review - Understanding cause and effect in Alzheimer's pathophysiology: Implications for clinical trials". Neuropathology and Applied Neurobiology. 46 (7): 623–640. doi:10.1111/nan.12642. PMID 32643143. S2CID 220429715.
Qureshi YH, Baez P, Reitz C (September 2020). "Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis". Molecular and Cellular Biology. 40 (19). doi:10.1128/MCB.00262-20. PMC 7491951. PMID 32690545.

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000069329 – Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000031696 – Ensembl, May 2017

nih.gov

pubmed.ncbi.nlm.nih.gov

Reitz C (April 2015). "The role of the retromer complex in aging-related neurodegeneration: a molecular and genomic review". Molecular Genetics and Genomics. 290 (2): 413–27. doi:10.1007/s00438-014-0939-9. PMC 4363161. PMID 25332075.
Reitz C (May 2018). "Retromer Dysfunction and Neurodegenerative Disease". Current Genomics. 19 (4): 279–288. doi:10.2174/1389202919666171024122809. PMC 5930449. PMID 29755290.
Brodin L, Shupliakov O (2018). "Retromer in Synaptic Function and Pathology". Frontiers in Synaptic Neuroscience. 10: 37. doi:10.3389/fnsyn.2018.00037. PMC 6207580. PMID 30405388.
Follett J, Bugarcic A, Collins BM, Teasdale RD (2017-07-01). "Retromer's Role in Endosomal Trafficking and Impaired Function in Neurodegenerative Diseases". Current Protein & Peptide Science. 18 (7): 687–701. doi:10.2174/1389203717666160311121246. PMID 26965691.
Trousdale C, Kim K (November 2015). "Retromer: Structure, function, and roles in mammalian disease". European Journal of Cell Biology. 94 (11): 513–21. doi:10.1016/j.ejcb.2015.07.002. PMID 26220253.
Rahman AA, Morrison BE (March 2019). "Contributions of VPS35 Mutations to Parkinson's Disease". Neuroscience. 401: 1–10. doi:10.1016/j.neuroscience.2019.01.006. PMC 6422337. PMID 30660673.
Vilariño-Güell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, Lincoln SJ, et al. (July 2011). "VPS35 mutations in Parkinson disease". American Journal of Human Genetics. 89 (1): 162–7. doi:10.1016/j.ajhg.2011.06.001. PMC 3135796. PMID 21763482.
Williams ET, Chen X, Moore DJ (2017-01-01). "VPS35, the Retromer Complex and Parkinson's Disease". Journal of Parkinson's Disease. 7 (2): 219–233. doi:10.3233/JPD-161020. PMC 5438477. PMID 28222538.
Cutillo G, Simon DK, Eleuteri S (November 2020). "VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology". Neurobiology of Disease. 145: 105056. doi:10.1016/j.nbd.2020.105056. PMID 32853677. S2CID 221277514.
Eleuteri S, Albanese A (2019-12-17). "VPS35-Based Approach: A Potential Innovative Treatment in Parkinson's Disease". Frontiers in Neurology. 10: 1272. doi:10.3389/fneur.2019.01272. PMC 6928206. PMID 31920908.
Deng H, Gao K, Jankovic J (May 2013). "The VPS35 gene and Parkinson's disease". Movement Disorders. 28 (5): 569–75. doi:10.1002/mds.25430. PMID 23536430. S2CID 16641707.
Sassone J, Reale C, Dati G, Regoni M, Pellecchia MT, Garavaglia B (April 2020). "The Role of VPS35 in the Pathobiology of Parkinson's Disease". Cellular and Molecular Neurobiology. 41 (2): 199–227. doi:10.1007/s10571-020-00849-8. PMID 32323152. S2CID 216076582.
Vergés M (2016-01-01). Jeon KW (ed.). "Retromer in Polarized Protein Transport". International Review of Cell and Molecular Biology. 323. Academic Press: 129–79. doi:10.1016/bs.ircmb.2015.12.005. ISBN 9780128048085. PMID 26944621.
Ghosh R, Pattison JS (2018). "Macroautophagy and Chaperone-Mediated Autophagy in Heart Failure: The Known and the Unknown". Oxidative Medicine and Cellular Longevity. 2018: 8602041. doi:10.1155/2018/8602041. PMC 5822756. PMID 29576856.
Bose A, Beal MF (October 2016). "Mitochondrial dysfunction in Parkinson's disease". Journal of Neurochemistry. 139 (S1): 216–231. doi:10.1111/jnc.13731. PMID 27546335. S2CID 32612919.
Weissbach A, Wittke C, Kasten M, Klein C (2019-01-01). Stamelou M, Höglinger GU (eds.). "'Atypical' Parkinson's disease - genetic". International Review of Neurobiology. 149. Academic Press: 207–235. doi:10.1016/bs.irn.2019.10.011. ISBN 9780128177303. PMID 31779813. S2CID 208357146.
Kim CY, Alcalay RN (April 2017). "Genetic Forms of Parkinson's Disease". Seminars in Neurology. 37 (2): 135–146. doi:10.1055/s-0037-1601567. PMID 28511254. S2CID 635105.
Lunati A, Lesage S, Brice A (November 2018). "The genetic landscape of Parkinson's disease" (PDF). Revue Neurologique. International SFN/SOMFA Meeting 2018. 174 (9): 628–643. doi:10.1016/j.neurol.2018.08.004. PMID 30245141.
Nguyen M, Wong YC, Ysselstein D, Severino A, Krainc D (February 2019). "Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease". Trends in Neurosciences. 42 (2): 140–149. doi:10.1016/j.tins.2018.11.001. PMC 6452863. PMID 30509690.
Abeysinghe AA, Deshapriya RD, Udawatte C (September 2020). "Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions". Life Sciences. 256: 117996. doi:10.1016/j.lfs.2020.117996. PMID 32585249. S2CID 220075087.
Boche D, Nicoll JA (December 2020). "Invited Review - Understanding cause and effect in Alzheimer's pathophysiology: Implications for clinical trials". Neuropathology and Applied Neurobiology. 46 (7): 623–640. doi:10.1111/nan.12642. PMID 32643143. S2CID 220429715.
Qureshi YH, Baez P, Reitz C (September 2020). "Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis". Molecular and Cellular Biology. 40 (19). doi:10.1128/MCB.00262-20. PMC 7491951. PMID 32690545.

ncbi.nlm.nih.gov

Reitz C (April 2015). "The role of the retromer complex in aging-related neurodegeneration: a molecular and genomic review". Molecular Genetics and Genomics. 290 (2): 413–27. doi:10.1007/s00438-014-0939-9. PMC 4363161. PMID 25332075.
Reitz C (May 2018). "Retromer Dysfunction and Neurodegenerative Disease". Current Genomics. 19 (4): 279–288. doi:10.2174/1389202919666171024122809. PMC 5930449. PMID 29755290.
Brodin L, Shupliakov O (2018). "Retromer in Synaptic Function and Pathology". Frontiers in Synaptic Neuroscience. 10: 37. doi:10.3389/fnsyn.2018.00037. PMC 6207580. PMID 30405388.
Rahman AA, Morrison BE (March 2019). "Contributions of VPS35 Mutations to Parkinson's Disease". Neuroscience. 401: 1–10. doi:10.1016/j.neuroscience.2019.01.006. PMC 6422337. PMID 30660673.
Vilariño-Güell C, Wider C, Ross OA, Dachsel JC, Kachergus JM, Lincoln SJ, et al. (July 2011). "VPS35 mutations in Parkinson disease". American Journal of Human Genetics. 89 (1): 162–7. doi:10.1016/j.ajhg.2011.06.001. PMC 3135796. PMID 21763482.
Williams ET, Chen X, Moore DJ (2017-01-01). "VPS35, the Retromer Complex and Parkinson's Disease". Journal of Parkinson's Disease. 7 (2): 219–233. doi:10.3233/JPD-161020. PMC 5438477. PMID 28222538.
Eleuteri S, Albanese A (2019-12-17). "VPS35-Based Approach: A Potential Innovative Treatment in Parkinson's Disease". Frontiers in Neurology. 10: 1272. doi:10.3389/fneur.2019.01272. PMC 6928206. PMID 31920908.
"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
Ghosh R, Pattison JS (2018). "Macroautophagy and Chaperone-Mediated Autophagy in Heart Failure: The Known and the Unknown". Oxidative Medicine and Cellular Longevity. 2018: 8602041. doi:10.1155/2018/8602041. PMC 5822756. PMID 29576856.
Nguyen M, Wong YC, Ysselstein D, Severino A, Krainc D (February 2019). "Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease". Trends in Neurosciences. 42 (2): 140–149. doi:10.1016/j.tins.2018.11.001. PMC 6452863. PMID 30509690.
Qureshi YH, Baez P, Reitz C (September 2020). "Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis". Molecular and Cellular Biology. 40 (19). doi:10.1128/MCB.00262-20. PMC 7491951. PMID 32690545.

semanticscholar.org

api.semanticscholar.org

Cutillo G, Simon DK, Eleuteri S (November 2020). "VPS35 and the mitochondria: Connecting the dots in Parkinson's disease pathophysiology". Neurobiology of Disease. 145: 105056. doi:10.1016/j.nbd.2020.105056. PMID 32853677. S2CID 221277514.
Deng H, Gao K, Jankovic J (May 2013). "The VPS35 gene and Parkinson's disease". Movement Disorders. 28 (5): 569–75. doi:10.1002/mds.25430. PMID 23536430. S2CID 16641707.
Sassone J, Reale C, Dati G, Regoni M, Pellecchia MT, Garavaglia B (April 2020). "The Role of VPS35 in the Pathobiology of Parkinson's Disease". Cellular and Molecular Neurobiology. 41 (2): 199–227. doi:10.1007/s10571-020-00849-8. PMID 32323152. S2CID 216076582.
Bose A, Beal MF (October 2016). "Mitochondrial dysfunction in Parkinson's disease". Journal of Neurochemistry. 139 (S1): 216–231. doi:10.1111/jnc.13731. PMID 27546335. S2CID 32612919.
Weissbach A, Wittke C, Kasten M, Klein C (2019-01-01). Stamelou M, Höglinger GU (eds.). "'Atypical' Parkinson's disease - genetic". International Review of Neurobiology. 149. Academic Press: 207–235. doi:10.1016/bs.irn.2019.10.011. ISBN 9780128177303. PMID 31779813. S2CID 208357146.
Kim CY, Alcalay RN (April 2017). "Genetic Forms of Parkinson's Disease". Seminars in Neurology. 37 (2): 135–146. doi:10.1055/s-0037-1601567. PMID 28511254. S2CID 635105.
Abeysinghe AA, Deshapriya RD, Udawatte C (September 2020). "Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions". Life Sciences. 256: 117996. doi:10.1016/j.lfs.2020.117996. PMID 32585249. S2CID 220075087.
Boche D, Nicoll JA (December 2020). "Invited Review - Understanding cause and effect in Alzheimer's pathophysiology: Implications for clinical trials". Neuropathology and Applied Neurobiology. 46 (7): 623–640. doi:10.1111/nan.12642. PMID 32643143. S2CID 220429715.

sorbonne-universite.fr

hal.sorbonne-universite.fr

Lunati A, Lesage S, Brice A (November 2018). "The genetic landscape of Parkinson's disease" (PDF). Revue Neurologique. International SFN/SOMFA Meeting 2018. 174 (9): 628–643. doi:10.1016/j.neurol.2018.08.004. PMID 30245141.